I agree that the clearing the market of flavors could help reduce youth utilization of e-cigarettes.

I am disappointed that it has taken so long to get to this point.

I firmly believe that many aspects of the youth vaping epidemic could have been addressed if the FDA had moved forward with reviewing all e-cigarettes on the market.

I don't see any reason why we in the United States, which are funding most of the research and development, should be paying three to four times what other countries are paying for exactly that same drug.

the number-one-selling drug in 2017 was Harvoni, which is a drug that takes care of hepatitis C. It was $1,100 per dose in the United States. It was $438 in Japan.

Humira, an anti-inflammatory therapy without a generic on the market and the best-selling prescription drug in the world, has doubled in price in the U.S. since 2012.

That has to come out. There has to be a process of negotiating. Otherwise, I don't know how we are going to effectively bring prices down.

Residential and commercial buildings are responsible for nearly 40 percent of U.S. carbon pollution--more than any other sector.

Our witnesses today have testified that more than half of the residential and commercial buildings that will be standing in 2050 have already been built.

I believe that clean building solutions must be consumer-driven in order to be successful.

Developing a 100 percent clean economy by 2050 is not going to be easy, but it is absolutely necessary.

Today's hearing is the committee's second this week and third in a series of ongoing hearings as we work to achieve 100 percent clean economy by 2050.